# Bronchial stenosis requires vigilance against tracheal mucormycosis: a case report

## TL;DR

This case report emphasizes the need to consider tracheal mucormycosis as a cause of breathing difficulties in patients with risk factors like diabetes.

## Contribution

The report adds to clinical awareness by highlighting mucormycosis as a rare but critical differential diagnosis for tracheal stenosis.

## Key findings

- Tracheal mucormycosis should be considered in patients with dyspnea and risk factors like uncontrolled diabetes.
- Early antifungal treatment improves outcomes by preventing progression to the lungs.
- Differentiating mucormycosis from other causes of tracheal stenosis is crucial for effective management.

## Abstract

This report highlights the importance of differentiating the etiology of dyspnea and tracheal stenosis. While acknowledging that tracheal stenosis can significantly cause respiratory distress, we emphasize the need to consider tracheal mucormycosis in the differential diagnosis, particularly in patients with risk factors such as uncontrolled diabetes and trauma. Early recognition and timely antifungal therapy remain crucial in managing this potentially fatal infection. Prioritizing early identification and treatment of mucormycosis before it progresses to the lungs can significantly improve patient outcomes and impact clinical practice.